LG
Ligand Pharmaceuticals Incorporated
LGND · Ligand Pharmaceuticals Incorporated · Healthcare
Up next day
7/12
58%
Fell despite growth
4/12
Good earnings ignored
Avg earnings move
±4.5%
typical swing on earnings
Price when beating
+0.2%
avg over 11 beats
Biggest single move
+9.8%
'24.3 · largest reaction
How this stock reacts to earnings
Traits seen across its recent earnings reactions
Beating estimates doesn't always lift it
Up the next day 6 of 11 beats (55%)
Tends to keep drifting the same way for days
Day-one direction continued · 67% of last 12
vs Healthcare sector avg (153 peers)
This
+0.7%
Sector
+0.4%
Avg next-day reaction
Earnings number vs guidance — which drives it?
How often the beat/miss matched the actual price move
The number and guidance move the price about equally
Moved opposite to results 6 of last 12 times (50%)
5xBeat but fell
Even a beat sells off if guidance disappoints
1xMissed but rose
Even a miss rebounds if guidance reassures
Earnings timeline · tap a bar for that quarter
Nov 5Before open
'26.9 expectedEst. EPS $2.30
Quarter ended 6/2026
Reported 2026-08-06
Next-day move
-2.3%
After 5 days -3.8%
vs Consensus$1.95→$2.37+21.5% beat
Beat by +21.5% but stock -2.3%
EPS
$2.37
YoY +48%
Revenue
$0.1B
YoY +34%
Next-Q guidance
—
N/A
Price around earnings
Fell despite growthvs market -2.9%p+29% run-up before
Earnings trend · last 12 quarters
EPS$2.37YoY +48%
'23.9'26.6
Revenue$0.1BYoY +34%
'23.9'26.6
Price vs earnings · last 12 quarters
↑Up↓Down
Bad news out
weak · up ↑
3x25%
Met expectations
good · up ↑
4x33%
Disappointment
weak · down ↓
1x8%
Good earnings ignored
good · down ↓
4x33%
← ← Weak earningsStrong earnings → →
Mostly 'honest' — good earnings, price up · 4 of 12q (33%)
Community · LGND
What do you think of this stock's earnings pattern?
···